Sign in

CIK 0002007919 · <br>Emerging growth company

Inhibrx Biosciences, Inc.

Sign in to watch
Ticker
INBX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
990613523
Phone
(858) 795-4220
Business address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA, CA, 92037
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. DEF 14A Proxy Proxy Statement
  4. 8-K Event Regulation FD disclosure · Other events
  5. 8-K Event Results of operations
  6. 10-K Report Annual Report
  7. 8-K Event Regulation FD disclosure
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. SCHEDULE 13G Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G Stake Statement of Beneficial Ownership
  11. 8-K Event Regulation FD disclosure · Other events
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. 8-K Event Regulation FD disclosure · Other events
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. 4 Open-market sale 10% owner sold 350,000 shares at $32.25 ($11,287,500)
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. EFFECT Other Notice of Effectiveness
  20. POS AM Other Post-effective Amendment for Registration Statement

Page 3 of 8 · 158 filings